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remarkable from 1 week after apex-sacri-
ficing VRS but not in apex-sparing VRS.
Drs Lunkenheimer and Anderson described
in their letter that resection of any part of
LV wall, including the septum, is tolerated
without impairing LV function when the
left ventricle is dilated. However, septal
anterior ventricular exclusion or pacopexy
reduces the septal and anterior wall without
amputating the LV apex and yields good
clinical results.13,14 We think those results
are compatible with our study.
In addition, results of some clinical
cases that underwent the apex-sparing VRS
in our unit have been excellent so far. Thus
we believe that it is important to reduce the
LV volume in dilated left ventricle with
severe LV dysfunction. Apex-sparing VRS
may improve the clinical results.
Although the hypothesis by Dr Torrent-
Guasp and colleagues is very interesting,15
there is no scientific proof so far. Therefore
the relationship between cause and result in
the improved LV function after the apex-
sparing VRS and preservation of single
muscle band is still unknown, and further
study will be required.
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Study of warm perfusion rather than
cardioplegia
To the Editor:
I read the article by Mallidi and col-
leagues,1 “The Short-term and Long-term
Effects of Warm or Tepid Cardioplegia,”
and raise the following concern. The title is
not descriptive of the protocols. Rather
than isolated cold or warm cardioplegia,
the article really describes cold and warm
total-body and cardiac perfusion strategies.
The article states, “In the warm or tepid
blood cardioplegia group, the systemic
temperature was maintained at 33°C to
37°C, and the blood cardioplegia was de-
livered at a temperature of 37°C. In the
tepid cardioplegia group, the systemic tem-
perature was permitted to drift passively
during the operation to 32°C to 34°C. The
temperature of the cardioplegia was 28° to
30°C. In the cold cardioplegia group, the
systemic temperature was actively cooled
to 25°C to 32°C, and the blood cardiople-
gia was actively cooled to a temperature of
5°C to 8°C.”
Other combinations may have similar
results, for example a warm corporeal per-
fusion strategy (drifting without active
cooling) and cold cardioplegia. The data do
not preclude such a result.
This group has done a nice job scientif-
ically studying and promoting warm perfu-
sion and protection strategies. I think that
describing their technique as “warm blood
cardioplegia” does not describe the strategy
adequately, and “warm perfusion strategy”
might be more accurate.
Edward B. Savage, MD
Rush–Presbyterian–St Luke’s Medical Center
Chicago, IL 60612
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Reply to the Editor:
Dr Savage correctly points out that the ar-
ticle published in the March issue of the
Journal by our group was not simply a
comparison of cold versus warm or tepid
cardioplegia, but rather a comparison of the
strategy of warm or tepid cardioplegia ver-
sus cold cardioplegia. The three cardiople-
gic and systemic perfusion strategies used
in patients undergoing isolated coronary
artery grafting surgery at our institution
were described in detail in the article. Other
possible cardioplegic and systemic perfu-
sion strategies (such as warm systemic per-
fusion with cold cardioplegia, tepid sys-
temic perfusion with cold cardioplegia,
systemic hypothermia with warm or tepid
cardioplegia, and so on) were not used in
our institution.
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